<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42209</article-id><article-id pub-id-type="doi">10.7554/eLife.42209</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-122155"><name><surname>Mullapudi</surname><given-names>Sri Teja</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3916-8148</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-28584"><name><surname>Helker</surname><given-names>Christian SM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-122156"><name><surname>Boezio</surname><given-names>Giulia LM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20399"><name><surname>Maischein</surname><given-names>Hans-Martin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122158"><name><surname>Sokol</surname><given-names>Anna M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80789"><name><surname>Guenther</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122157"><name><surname>Matsuda</surname><given-names>Hiroki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8639-2719</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-104169"><name><surname>Kubicek</surname><given-names>Stefan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0855-8343</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122159"><name><surname>Graumann</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104717"><name><surname>Yang</surname><given-names>Yu Hsuan Carol</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7189"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0382-0026</contrib-id><email>Didier.Stainier@mpi-bn.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Developmental Genetics</institution><institution>Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Biomolecular Mass Spectrometry</institution><institution>Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">ECCPS Bioinformatics and Deep Sequencing Platform</institution><institution>Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences</institution><addr-line><named-content content-type="city">Vienna</named-content></addr-line><country>Austria</country></aff><aff id="aff5"><label>5</label><institution>German Centre for Cardiovascular Research</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>White</surname><given-names>Richard M</given-names></name><role>Reviewing Editor</role><aff><institution>Memorial Sloan Kettering Cancer Center</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>McCarthy</surname><given-names>Mark I</given-names></name><role>Senior Editor</role><aff><institution>University of Oxford</institution><country>United Kingdom</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Faculty of Biology, Cell Signaling and Dynamics, Philipps-University Marburg, Marburg, Germany</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>06</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e42209</elocation-id><history><date date-type="received" iso-8601-date="2018-09-20"><day>20</day><month>09</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-03"><day>03</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Mullapudi et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Mullapudi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42209-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.42209.001</object-id><p>Pathways modulating glucose homeostasis independently of insulin would open new avenues to combat insulin resistance and diabetes. Here, we report the establishment, characterization, and use of a vertebrate ‘insulin-free’ model to identify insulin-independent modulators of glucose metabolism. <italic>insulin</italic> knockout zebrafish recapitulate core characteristics of diabetes and survive only up to larval stages. Utilizing a highly efficient endoderm transplant technique, we generated viable chimeric adults that provide the large numbers of <italic>insulin</italic> mutant larvae required for our screening platform. Using glucose as a disease-relevant readout, we screened 2233 molecules and identified three that consistently reduced glucose levels in <italic>insulin</italic> mutants. Most significantly, we uncovered an insulin-independent beneficial role for androgen receptor antagonism in hyperglycemia, mostly by reducing fasting glucose levels. Our study proposes therapeutic roles for androgen signaling in diabetes and, more broadly, offers a novel in vivo model for rapid screening and decoupling of insulin-dependent and -independent mechanisms.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.42209.002</object-id><title>eLife digest</title><p>Diabetes is a disease that affects the ability of the body to control the level of sugar in the blood. Individuals with diabetes are unable to make a hormone called insulin – which normally stimulates certain cells to absorb sugar from the blood – or their cells are less able to respond to this hormone. Most treatments for diabetes involve replacing the lost insulin or boosting the hormone’s activity in the body. However, these treatments can also cause individuals to gain weight or become more resistant to insulin, making it harder to control blood sugar levels.</p><p>In addition to insulin, several other factors regulate the levels of sugar in the blood and some of them may operate independently of insulin. However, little is known about such factors because it is impractical to carry out large-scale screens to identify drugs that target them in humans or mice, which are often used as experimental models for human biology.</p><p>To overcome this challenge, Mullapudi et al. turned to another animal known as the zebrafish and generated mutant fish that lack insulin. The mutant zebrafish had similar problems with regulating sugar levels as those observed in humans and mice with diabetes. This observation suggests that insulin is just as important in zebrafish as it is in humans and other mammals.</p><p>The mutant zebrafish did not survive into adulthood, and so Mullapudi et al. transplanted healthy tissue into the zebrafish to allow them to produce enough insulin to survive. These adult zebrafish produced many offspring that still carried the insulin mutation. Mullapudi et al. used these mutant offspring to screen over 2,000 drugs for their ability to decrease blood sugar levels in the absence of insulin. The screen identified three promising candidate drugs, including a molecule that interferes with a receptor for a signal known as androgen.</p><p>These findings will help researchers investigate new ways to treat diabetes. In the future, the screening approach developed by Mullapudi et al. could be adapted to search for new drugs to treat other human metabolic conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>glucose homeostasis</kwd><kwd>insulin</kwd><kwd>drug screen</kwd><kwd>androgen</kwd><kwd>transplantation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><award-id>Open-access funding</award-id><principal-award-recipient><name><surname>Mullapudi</surname><given-names>Sri Teja</given-names></name><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Boezio</surname><given-names>Giulia LM</given-names></name><name><surname>Maischein</surname><given-names>Hans-Martin</given-names></name><name><surname>Sokol</surname><given-names>Anna M</given-names></name><name><surname>Guenther</surname><given-names>Stefan</given-names></name><name><surname>Matsuda</surname><given-names>Hiroki</given-names></name><name><surname>Graumann</surname><given-names>Johannes</given-names></name><name><surname>Yang</surname><given-names>Yu Hsuan Carol</given-names></name><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Deutsches Zentrumfür Herz-Kreislaufforschung</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sokol</surname><given-names>Anna M</given-names></name><name><surname>Graumann</surname><given-names>Johannes</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Zebrafish insulin mutants serve as an innovative platform to identify novel mechanisms regulating glucose homeostasis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Characterized by the inability to control blood glucose levels, diabetes is a metabolic disease of major socio-economic concern. Blood glucose levels are regulated by multiple tissues including the pancreas, muscle, liver, adipocytes, gut and kidney (<xref ref-type="bibr" rid="bib18">Defronzo, 2009</xref>). Signals from endocrine hormones are integrated by each tissue to effectively maintain glucose homeostasis, and aberrations in this interplay underlie the pathogenesis of diabetes. Currently, seven classes of antidiabetic drugs exist, of which only three function without increasing circulating insulin levels and only one that definitively functions independently of insulin (<xref ref-type="bibr" rid="bib15">Chaudhury et al., 2017</xref>). Restoring normoglycemia independently of insulin secretion or action could delay disease progression as an improved glycemic status can restore β-cell mass and function (<xref ref-type="bibr" rid="bib79">Wang et al., 2014</xref>). Lower dependence on insulin-stimulating therapies can also prevent hyperinsulinemia-driven insulin resistance (<xref ref-type="bibr" rid="bib65">Shanik et al., 2008</xref>) and obesity (<xref ref-type="bibr" rid="bib47">Mehran et al., 2012</xref>). In contrast to insulin stimulators, Biguanides (e.g., Metformin) and Thiazolidinediones (e.g., Pioglitazone) are effective antidiabetic agents that primarily sensitize tissues to insulin (reviewed by (<xref ref-type="bibr" rid="bib66">Soccio et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Rena et al., 2017</xref>)). Likewise, sodium-glucose transporter two inhibitors (e.g., Dapagliflozin) have a complementary mechanism of reducing glucose reabsorption in the kidney (<xref ref-type="bibr" rid="bib7">Bailey et al., 2013</xref>). Increasing evidence points to additional molecular pathways that can improve metabolic homeostasis independently of insulin, for instance, using leptin therapy (<xref ref-type="bibr" rid="bib55">Neumann et al., 2016</xref>) or exercise (<xref ref-type="bibr" rid="bib69">Stanford and Goodyear, 2014</xref>). Interestingly, currently prescribed drugs were discovered from their historical use in herbal medicine (<xref ref-type="bibr" rid="bib22">Ehrenkranz et al., 2005</xref>; <xref ref-type="bibr" rid="bib8">Bailey, 2017</xref>) or from screens directed against hyperlipidemia (<xref ref-type="bibr" rid="bib25">Fujita et al., 1983</xref>). However, so far, an unbiased search for insulin-independent pathways controlling glucose metabolism has remained elusive, primarily due to the lack of a disease-relevant animal model for rapid screening. Due to its high fecundity and amenability to chemical screening, the zebrafish serves as an excellent platform to study diabetes, and it has been successfully used to study β-cell mass and activity, as well as glucose metabolism (<xref ref-type="bibr" rid="bib4">Andersson et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Gut et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Tsuji et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Nath et al., 2015</xref>; <xref ref-type="bibr" rid="bib41">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">White et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Gut et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Matsuda et al., 2018</xref>). Here, using the zebrafish model, we generated an innovative drug discovery strategy, screened chemical libraries and specifically identified insulin-independent effects of androgen signaling on glucose homeostasis.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><sec id="s2-1"><title><italic>insulin</italic> is crucial for zebrafish metabolic homeostasis already at larval stages</title><p>Insulin plays a central role in glucose homeostasis by increasing glucose uptake in peripheral tissues, promoting glycogenesis in the liver and decreasing glucose production by inhibiting glucagon secretion (<xref ref-type="bibr" rid="bib6">Aronoff et al., 2004</xref>). We generated zebrafish devoid of insulin signaling and determined the degree to which these mutants recapitulate core features of diabetic metabolism observed in mammals. The zebrafish genome contains two insulin genes – <italic>insulin (ins)</italic> and <italic>insulinb (insb).</italic> Using CRISPR/Cas9 mutagenesis, we generated a 16 bp deletion allele of <italic>ins</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and a 10 bp insertion allele of <italic>insb</italic>. Although <italic>ins</italic> and <italic>insb</italic> mutant embryos appear morphologically unaffected (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), Insulin was entirely absent in pancreatic islets of <italic>ins</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), whereas there was no observable change in <italic>insb</italic> mutant islets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and C</xref>). <italic>ins</italic> mutants exhibit a drastic increase in total glucose levels (up to 10-fold), measured from 1 to 6 days post fertilization (dpf) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Additionally, staining for lipid content using Nile Red revealed large unused yolk reserves (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), suggesting defects in lipid absorption and processing. Due to a combination of these metabolic defects, <italic>ins</italic> mutants do not survive beyond 12 dpf (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Moreover, although 3 month old (adult) <italic>ins +/- </italic>animals are normoglycemic (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>), 50 dpf (juvenile) <italic>ins +/- </italic>animals are noticeably smaller (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), consistent with a role for Insulin in growth control (<xref ref-type="bibr" rid="bib51">Nakae et al., 2001</xref>). <italic>insb</italic> mutants, on the other hand, are viable and fertile. During WT development, <italic>insb</italic> expression is minimal beyond 48 hpf (<xref ref-type="bibr" rid="bib57">Papasani et al., 2006</xref>; <xref ref-type="bibr" rid="bib81">White et al., 2017</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), and it is undetectable in adult β-cells (<xref ref-type="bibr" rid="bib71">Tarifeño-Saldivia et al., 2017</xref>). To assess whether it is capable of function, we overexpressed <italic>insb</italic> under the <italic>ins</italic> promoter. Under the hyperglycemic conditions resulting from morpholino (MO)-mediated <italic>ins</italic> knockdown, <italic>insb</italic> overexpression successfully lowered glucose levels, thus indicating that <italic>insb</italic> is functional (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). However, due to the post-embryonic expression of <italic>ins</italic>, survival and metabolic homeostasis in zebrafish depends primarily on <italic>ins</italic>. This predominant role of <italic>ins</italic> distinguishes the zebrafish insulins from the redundant metabolic roles of mouse <italic>Ins1</italic> and <italic>Ins2</italic> (<xref ref-type="bibr" rid="bib20">Duvillié et al., 1997</xref>). To further explore the nature of the metabolic defects in zebrafish <italic>ins</italic> mutants, we probed the proteome of 108 hpf <italic>ins</italic> mutants compared to their WT siblings and assessed this dataset relative to seven other proteomes from diabetic tissues of rodent or human origin (<xref ref-type="bibr" rid="bib33">Hwang et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">Mullen and Ohlendieck, 2010</xref>; <xref ref-type="bibr" rid="bib27">Giebelstein et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Valle et al., 2012</xref>); S.-J. <xref ref-type="bibr" rid="bib37">Kim et al., 2014a</xref>; <xref ref-type="bibr" rid="bib13">Capuani et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Braga et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Zabielski et al., 2016</xref>). Strikingly, pathways like gluconeogenesis, mitochondrial dysfunction, sirtuin signaling, and oxidative phosphorylation, which were affected in diabetic conditions across these studies, were similarly disrupted in zebrafish <italic>ins</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1F</xref> and <xref ref-type="supplementary-material" rid="supp1">supplementary file 1</xref>). Together, these findings indicate that zebrafish <italic>ins</italic> is crucial for metabolic homeostasis and survival, and that its absence causes core features of diabetic metabolism already at larval stages.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.42209.003</object-id><label>Figure 1.</label><caption><title><italic>insulin</italic> is crucial for zebrafish metabolic homeostasis.</title><p>(<bold>A</bold>) CRISPR target site in the <italic>insulin</italic> gene, with PAM sequence highlighted, and the resulting 16 bp deletion allele (below). (<bold>A’</bold>) Schematic of wild-type Insulin protein and the predicted mutant protein which contains novel sequence (black). (<bold>B</bold>) Confocal projection images of the pancreatic islet in 96 hpf <italic>Tg(ins:GFP) ins +/+</italic> and <italic>ins -/-</italic> animals immunostained for Insulin (red) and Glucagon (cyan). (<bold>C</bold>) Free glucose levels in wild-type and mutant animals from 1 to 6 dpf; mean ± SEM, n = 2–4 replicates. (<bold>D</bold>) Nile Red staining (green) for neutral lipids in 120 hpf wild-type (top) and mutant (bottom) larvae, with yolk lipid content outlined (yellow dots). (<bold>E</bold>) Genotype distribution from <italic>ins ± </italic>incross, calculated as the percentage of total animals at each stage; mean ± SEM, n = 32 animals at each stage. (<bold>F</bold>) Heat map of the proteomic signature of zebrafish <italic>ins</italic> mutants at 120 hpf compared to signatures from rodent (<bold>R</bold>) and human (<bold>H</bold>) diabetic proteome studies. Canonical pathways implicated in most studies are listed first. P-value cut-off set at &lt;0.05. Scale bars: 10 μm (<bold>B</bold>), 500 μm (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42209.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title><italic>ins,</italic> and not <italic>insb</italic>, is the predominant paralog expressed in zebrafish pancreatic islets.</title><p>(<bold>A</bold>) Brightfield images of 72 hpf wild-type, <italic>ins</italic> mutant and <italic>insb</italic> mutant larvae. (<bold>B–C</bold>) Confocal plane images of the pancreatic islet in 72 hpf wild-type and <italic>insb</italic> mutant larvae stained for Insulin (white). (<bold>D</bold>) Fasting blood glucose levels in three mpf wild-type and <italic>ins ± </italic>animals; mean ± SEM, n = 11 animals. (<bold>E</bold>) Body length measurements of 50 dpf wild-type and <italic>ins ± </italic>animals; mean ± SEM, n = 5–6 animals. (<bold>F</bold>) mRNA expression time course of <italic>ins</italic> and <italic>insb</italic> during zebrafish development from 0 to 120 hpf. (<bold>G</bold>) 4 ng of control (ctrl) or <italic>ins</italic> morpholino (MO) was injected in non-transgenic or <italic>Tg(ins:insb</italic>) (<italic>insb</italic> OE) embryos at the one cell stage and glucose levels measured at 96 hpf; mean ± SEM, n = 3 replicates. Scale bars: 250 μm (<bold>A</bold>), 5 μm (<bold>C, D</bold>). <italic>P</italic> values from t-tests.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Highly efficient endoderm transplant technique rescues <italic>ins</italic> mutants to adulthood</title><p>Screening of small molecules in <italic>ins</italic> mutants requires large numbers of mutant animals. However, the early lethality of <italic>ins</italic> mutants did not allow the generation of adult animals that can be incrossed. To overcome this obstacle, we used an efficient endoderm induction (<xref ref-type="bibr" rid="bib36">Kikuchi et al., 2001</xref>) and transplantation technique (<xref ref-type="bibr" rid="bib68">Stafford et al., 2006</xref>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) to selectively modify endodermal tissues without altering the germline. <italic>Tg(ins:DsRed); ins +/+</italic> embryos were injected with <italic>sox32</italic> mRNA at the one-cell stage, conferring an endodermal fate on all cells. Between 3 to 4 hpf, cells were transplanted from these embryos to the mesendoderm of similarly staged embryos from <italic>Tg(ins:RasGFP); ins +/- </italic>incrosses. This transplantation procedure was remarkably efficient at contributing to host endoderm (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–A’’</xref>), and the pancreatic islet of nearly every host embryo contained both donor derived (i.e., <italic>ins +/+</italic>) as well as host β-cells (<xref ref-type="fig" rid="fig2">Figure 2B–B’’</xref>). These chimeric animals were raised to adulthood and genotyping (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B–C</xref>) revealed a near Mendelian ratio of mutant animals (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). In summary, these chimeric animals contain <italic>ins +/+</italic> endodermal tissues but retain an <italic>ins -/-</italic> germline, thereby allowing an all-mutant progeny to be obtained by incrossing.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.42209.005</object-id><label>Figure 2.</label><caption><title>Highly efficient endoderm transplant technique rescues <italic>ins</italic> mutants to adulthood.</title><p>(<bold>A</bold>) Schematic depicting the endoderm transplantation protocol; <italic>sox32</italic> mRNA-injected <italic>ins +/+</italic> donor cells (orange) were transplanted into host embryos (blue) to form chimeric animals. (<bold>B–B’’</bold>) Confocal projection images of the pancreatic islet of a 48 hpf chimeric animal showing β-cells from the host (green, (<bold>B’</bold>) and the transplanted <italic>ins +/+</italic> cells (magenta, (<bold>B</bold>). (<bold>C</bold>) Genotype distribution in the raised three mpf chimeric animals, determined by genotyping fin tissue; mean ± SEM, n = 3 transplant experiments, 18–32 animals per experiment. Scale bar: 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42209.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title><italic>sox32</italic> mRNA-injected cells contribute to host endoderm upon transplantation.</title><p>(<bold>A–A”</bold>) Confocal images of a 48 hpf host embryo injected with <italic>H2B-mCherry</italic> mRNA (magenta) and transplanted with <italic>Tg</italic>(<italic>sox17:</italic>GFP) expressing donor endoderm showing the chimeric islet (yellow arrowhead). (<bold>B</bold>) High-resolution melt analysis patterns for genotyping <italic>ins +/+</italic> (blue), <italic>ins +/-</italic> (green) and <italic>ins -/-</italic> (brown) animals. (<bold>C</bold>) Representative example of genotyping 31 chimeric adults, revealing 8 of 31 animals to be mutant (brown). Scale bar: 200 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Small molecule screen in <italic>ins</italic> mutants reveals insulin-independent modulators of glucose metabolism</title><p>With the ability to obtain large numbers of <italic>ins</italic> mutant embryos, we next aimed to analyze the effect of known glucose homeostasis modulators and also to screen for novel ones. We tested the effects of molecules that have been proposed to help normalize glucose levels in an insulin-independent manner as well as others that do so in an insulin-dependent manner. Anti-diabetics such as metformin, pioglitazone and dapagliflozin, as well as the Lyn kinase activator MLR1023 (<xref ref-type="bibr" rid="bib64">Saporito et al., 2012</xref>), were tested. We also tested fraxidin, identified in a screen for molecules that increase glucose uptake in zebrafish (<xref ref-type="bibr" rid="bib40">Lee et al., 2013</xref>). Surprisingly, metformin and MLR1023 exhibited no glucose-lowering effect in <italic>ins</italic> mutants, suggesting that they act more as sensitizers of insulin signaling rather than independently of insulin (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In <italic>ins</italic> mutants, Pck1 levels are higher compared to wild types (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), suggesting increased gluconeogenesis in the absence of the inhibitory action of insulin. This observation is also supported by the drastic reduction of glucose levels in <italic>ins</italic> mutants treated with the Pck1 inhibitor, 3 MPA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Metformin has well-known abilities to reduce hepatic gluconeogenesis, and it also reduces glucose levels in isoprenaline-treated wild-type zebrafish (<xref ref-type="bibr" rid="bib30">Gut et al., 2013</xref>). However, metformin’s inability to reduce glucose levels in zebrafish <italic>ins</italic> mutants reveals metformin’s dependence on insulin signaling for its action. MLR1023’s glucose level lowering effects have been proposed to be insulin-dependent (<xref ref-type="bibr" rid="bib56">Ochman et al., 2012</xref>), and thus, its inability to lower glucose levels in zebrafish <italic>ins</italic> mutants further suggests the lack of any insulin signaling in these animals. On the other hand, fraxidin, dapagliflozin, and pioglitazone reduced glucose levels by 5, 12, and 11% respectively (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), thus attributing part of their glucose lowering effect to an insulin-independent mechanism. The lack of adipose tissue (<xref ref-type="bibr" rid="bib48">Minchin and Rawls, 2017</xref>) and the primitive nature of kidney (pronephros) function at these developmental stages (<xref ref-type="bibr" rid="bib23">Elmonem et al., 2018</xref>) may result in an incomplete recapitulation of adipose signaling and renal function on glucose homeostasis (<xref ref-type="bibr" rid="bib18">Defronzo, 2009</xref>). This limitation could also explain the small magnitude of glucose level reduction observed with the PPARγ agonist or SGLT2 inhibitor treatments in zebrafish <italic>ins</italic> mutants. Based on these data with known glucose level lowering drugs, we decided to screen chemical libraries to identify molecules that could reduce glucose levels by more than 10% in zebrafish <italic>ins</italic> mutants.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.42209.007</object-id><label>Figure 3.</label><caption><title>Small molecule screen in <italic>ins</italic> mutants reveals insulin-independent modulators of glucose metabolism.</title><p>(<bold>A</bold>) Relative glucose levels in 120 hpf <italic>ins</italic> mutant larvae after 36 hr of treatment with anti-diabetic drugs (dapagliflozin, pioglitazone, metformin) or reported insulin mimetics (MLR1023, Fraxidin) or the Pck1 inhibitor, 3 MPA; mean ± SEM, n = 3–7 replicates. (<bold>B</bold>) Schematic representation of the screening pipeline: <italic>ins</italic> mutant larvae were treated with small molecules starting at 84 hpf and free glucose levels measured at 120 hpf. (<bold>C</bold>) Scatter plot showing relative change in glucose levels upon treatment with 2233 small molecules. X and Y axes represent two replicates performed for each drug, with the dotted purple lines marking 0.9 on each axis. 72 molecules satisfied the pre-specified cut-off. (<bold>D</bold>) Relative glucose levels at 120 hpf upon treatment of <italic>ins</italic> mutants with the three hits – ODQ, Vorinostat, and Flutamide; mean ± SEM, n = 6–7 replicates. <italic>P</italic> values from t-tests.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42209.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>A 96-well plate-adapted protocol to measure glucose levels is suitable for small molecule screening.</title><p>(<bold>A</bold>) Plotting the measured glucose levels interpolated from the regular standard curve (blue) shows a shifted curve in the presence of lysis buffer (orange) with a dynamic range still suitable for measuring glucose levels. (<bold>B</bold>) Schematic showing the plate-adapted glucose readout assay. (<bold>C</bold>) Relative free glucose levels upon treatment of wild-type larvae from 4 to 6 dpf with the beta-adrenergic agonist isoprenaline (Iso) or both isoprenaline and metformin (Iso +Met); mean ± SEM, n = 4–5 replicates. (<bold>D</bold>) Structures of the hits - flutamide, ODQ and vorinostat. <italic>P</italic> values from t-tests.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To rapidly measure free glucose levels in a 96-well plate format, we adapted a kit-based protocol that is sensitive to endogenous changes in larval glucose levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>), and established a screening pipeline (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We screened 2233 molecules in 2 replicates at 10 μM concentration and found three hits (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) that reproducibly reduced glucose levels upon retesting with independent chemical stocks and the unmodified standard glucose measurement kit. These three hits - flutamide (androgen receptor antagonist), ODQ (soluble guanylyl cyclase (sGC) inhibitor (<xref ref-type="bibr" rid="bib11">Boulton et al., 1995</xref>)) and vorinostat (broad HDAC inhibitor (<xref ref-type="bibr" rid="bib24">Finnin et al., 1999</xref>)) were found, upon retesting multiple times, to reduce glucose levels by 40, 22% and 19%, respectively (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). sGC inhibition by ODQ has been previously reported to increase net hepatic glucose uptake and shift the balance towards glycogenesis (<xref ref-type="bibr" rid="bib2">An et al., 2010</xref>). Contrary to our findings, clinical use of vorinostat has been associated with hyperglycemia as a side effect (<xref ref-type="bibr" rid="bib45">Mann et al., 2007</xref>). This difference could be due to the broad nature of Vorinostat’s HDAC inhibition properties including anti-proliferative effects (<xref ref-type="bibr" rid="bib61">Richon, 2006</xref>), which are likely to affect developmental processes in zebrafish <italic>ins</italic> mutants. These three drugs did not prolong the survival of zebrafish <italic>ins</italic> mutants, likely because lowering glucose levels alone was not sufficient to normalize all the metabolic, growth, and differentiation processes (<xref ref-type="bibr" rid="bib70">Taniguchi et al., 2006</xref>) dysregulated in these animals.</p></sec><sec id="s2-4"><title>Androgen receptor (AR) antagonism reduces glucose levels in hyperglycemic larval and adult animals</title><p>Given the strong reduction in glucose levels observed after flutamide treatments, we further tested the hypothesis that glucose levels in <italic>ins</italic> mutants were being reduced through androgen receptor antagonism. First, flutamide caused a dose-dependent decrease in glucose levels in <italic>ins</italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Second, we treated <italic>ins</italic> mutants with AR antagonists of two types: (i) steroidal (Cyproterone) and (ii) non-steroidal (nilutamide, hydroxyflutamide, bicalutamide, enzalutamide), and observed a consistent decrease in glucose levels across all treatments, albeit at varying efficiency (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), possibly reflecting the different efficacy of these antagonists towards zebrafish AR (<xref ref-type="bibr" rid="bib59">Raynaud et al., 1979</xref>; <xref ref-type="bibr" rid="bib72">Teutsch et al., 1994</xref>; <xref ref-type="bibr" rid="bib74">Tran et al., 2009</xref>). Finally, to modulate AR protein levels, we injected 1 ng of control or <italic>ar</italic> MO into one-cell stage embryos and observed a reduction of glucose levels in <italic>ar</italic> MO injected <italic>ins</italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) but not in <italic>ar</italic> MO injected wild-type animals (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). These data support a role, and a benefit, for antagonizing AR specifically in hyperglycemic conditions.</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.42209.009</object-id><label>Figure 4.</label><caption><title>Androgen receptor (AR) antagonism reduces glucose levels in hyperglycemic larvae and adults.</title><p>(<bold>A</bold>) Relative glucose levels in <italic>ins</italic> mutants at 120 hpf upon treatment with various AR antagonists starting at 84 hpf; mean ± SEM, n = 3–7 replicates. (<bold>B</bold>) Glucose levels in 72 hpf <italic>ins</italic> mutants after injection with 1 ng of ctrl or <italic>ar</italic> MO; mean ± SEM, n = 3 replicates. (<bold>C</bold>) Glucose levels in 72 hpf wild types after injection with 1 ng of ctrl or <italic>ar</italic> MO; mean ± SEM, n = 4 replicates. (<bold>D</bold>) RNA-seq analysis of 120 hpf <italic>ins</italic> mutant larvae treated with flutamide or cyproterone starting at 84 hpf, showing differentially expressed genes (DEGs) compared to DMSO-treated larvae in blue and green, respectively. Red dots indicate DEGs common to both treatments. (<bold>E</bold>) Workflow used to filter candidate genes: 40 DEGs modulated in the same direction (both up or both down) were analyzed in relation to the microarray dataset (<italic>ins</italic> mutant vs phenotypically wild-type 108 hpf larvae). (<bold>F</bold>) Glucose levels measured in adult <italic>Tg(ins:NTR)</italic> animals after β-cell ablation and intraperitoneal injection with vehicle (DMSO) or flutamide; mean ± SEM, n = 6–8 animals. <italic>P</italic> values from t-tests.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42209.010</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Flutamide reduces glucose levels in a dose-dependent manner, possibly exerting its effects through liver gluconeogenic enzymes.</title><p>(<bold>A</bold>) Dose response curve of the glucose lowering effect of flutamide in <italic>ins</italic> mutant larvae, treated from 84 to 120 hpf; mean ± SEM, n = 3 replicates. (<bold>B</bold>) Wholemount in situ hybridization for <italic>ar</italic> expression in 120 hpf wild-type and <italic>ins</italic> mutant larvae showing signal in the brain and liver (red arrowheads). (<bold>C</bold>) The 12 genes differentially regulated in <italic>ins</italic> mutants compared to non-mutant siblings and modulated in the opposite direction upon treatment with flutamide or cyproterone compared to DMSO; listed with their fold change (Log<sub>2</sub> scale) and expression levels under control condition (base mean reads); genes are ordered by the fold change in the flutamide vs DMSO condition. (<bold>D</bold>) Schematic of <italic>insig1</italic> and <italic>btg2</italic> gene loci, with location of transcription start site (TSS) and androgen response elements (ARE, blue arrowheads). (<bold>E</bold>) Schematic of vehicle vs flutamide treatment of <italic>Tg(ins:NTR)</italic> adult animals following β-cell ablation with metronidazole (MTZ) injection to induce hyperglycemia. Scale bar: 250 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42209-fig4-figsupp1-v2.tif"/></fig></fig-group><p>A number of mechanisms have been proposed to explain the predisposition of women with androgen excess to diabetes, including insulin resistance, visceral adiposity, and β-cell dysfunction (<xref ref-type="bibr" rid="bib53">Navarro et al., 2015</xref>). Under high fat diet, a combination of neuronal and pancreatic β-cell specific roles for AR have been proposed to predispose female mice with androgen excess to diabetes (<xref ref-type="bibr" rid="bib54">Navarro et al., 2018</xref>). Supporting this role, <italic>ar</italic> gene expression was observed in the zebrafish central nervous system and, additionally, in the liver (<xref ref-type="bibr" rid="bib28">Gorelick et al., 2008</xref>) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). To investigate how AR antagonism mediates glucose level reduction in zebrafish <italic>ins</italic> mutants, we used a transcriptomic approach. RNA-Seq analyses of 120 hpf <italic>ins</italic> mutants treated with flutamide or cyproterone revealed 504 and 476 differentially expressed genes (DEGs) compared to vehicle treated mutants (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), respectively. Of these DEGs, 40 were regulated in parallel (both up or both down) for both AR antagonists tested, likely highlighting the common AR-specific effects. Cross-referencing these 40 genes with a transcriptomic comparison of <italic>ins</italic> mutants to phenotypically wild-type siblings, led to 12 genes (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) that were differentially expressed upon loss of <italic>ins</italic>, and were partially or fully restored to wild-type levels upon treatment with AR antagonists (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Amongst these 12 genes, <italic>btg2</italic> and <italic>insig1</italic> have been reported to play crucial roles in controlling liver gluconeogenesis (<xref ref-type="bibr" rid="bib14">Carobbio et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Kim et al., 2014b</xref>), and they also contain two androgen response elements (AREs) close to their transcription start site (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Additionally, upon intraperitoneal injections of flutamide in hyperglycemic adult animals (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>), we observed 19% lower fasting plasma glucose levels (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), likely due to reduced hepatic glucose production. Our findings corroborate the observations of better anthropometric indices previously observed with flutamide (<xref ref-type="bibr" rid="bib62">Sahin et al., 2004</xref>) or metformin +flutamide combination therapies (<xref ref-type="bibr" rid="bib26">Gambineri et al., 2004</xref>; <xref ref-type="bibr" rid="bib1">Amiri et al., 2014</xref>), and attribute a part of this beneficial effect to flutamide’s insulin-independent action through AR antagonism.</p><p>In conclusion, to the best of our knowledge, ours is the first study to report the generation and use of a rapid screening strategy to identify insulin-independent pathways modulating metabolism in vertebrates. Given the recent success of SGLT2 inhibitors as combination therapy in diabetes (<xref ref-type="bibr" rid="bib7">Bailey et al., 2013</xref>), our study is an important step towards identifying more insulin-independent mechanisms governing glucose homeostasis. One of the limitations of our screen is the relatively low size of the chemical library screened. However, as the endoderm transplant technique reported here can be combined with several genetic or metabolic readouts, future studies with larger chemical libraries should unveil mechanisms governing other disease-relevant phenomena as well. Such comprehensive insight into insulin-independent mechanisms and their interactions with insulin signaling in homeostasis and disease will open new avenues for designing therapies to treat metabolic disorders.</p></sec></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>ins<sup>bns102</sup></italic></td><td>This paper</td><td/><td>16 bp deletion allele of <italic>ins</italic> (Gene ID: 30262)</td></tr><tr><td>Antibody</td><td>α-Insulin (Guinea Pig <break/>Polyclonal)</td><td>Dako</td><td>A0564</td><td>(1:300)</td></tr><tr><td>Sequence-based reagent</td><td><italic>sox32</italic></td><td><xref ref-type="bibr" rid="bib36">Kikuchi et al., 2001</xref></td><td/><td>(RNA)</td></tr><tr><td>Commercial assay or kit</td><td>mMessage mMachine SP6 Transcription Kit</td><td>ThermoFisher</td><td>AM1340</td><td/></tr><tr><td>Commercial assay or kit</td><td>Glucose assay kit</td><td>Merck</td><td>CBA086</td><td/></tr><tr><td>Software, algorithm</td><td>ZEN Blue 2012</td><td>Zeiss, Germany</td><td/><td/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism 7</td><td>GraphPad Software, <break/>California</td><td/><td/></tr></tbody></table></table-wrap><sec id="s3-1"><title>Zebrafish lines</title><p>Zebrafish husbandry was performed under standard conditions in accordance with institutional (MPG) and national ethical and animal welfare guidelines. The transgenic and mutant lines used in this study are <italic>Tg</italic>(<italic>ins:DsRed</italic>)<italic><sup>m1018</sup></italic> (<xref ref-type="bibr" rid="bib3">Anderson et al., 2009</xref>), <italic>Tg(‐4.0ins:GFP)<sup>zf5</sup></italic> (<xref ref-type="bibr" rid="bib32">Huang et al., 2001</xref>), <italic>Tg(sox17:GFP)<sup>s870</sup></italic> (<xref ref-type="bibr" rid="bib63">Sakaguchi et al., 2006</xref>), <italic>Tg</italic>(<italic>ins:Flag-NTR, cryaa:mCherry</italic>)<italic><sup>s950</sup></italic> (<xref ref-type="bibr" rid="bib4">Andersson et al., 2012</xref>), <italic>Tg(ins:EGFP-HRas, cryaa:mCherry)<sup>bns294</sup></italic>, <italic>Tg(ins:TagRFPt-P2A-insB)<sup>bns285</sup></italic>, <italic>ins<sup>bns102</sup></italic> (<italic>ins</italic> mutants), and <italic>insb<sup>bns295</sup></italic> (<italic>insb</italic> mutants).</p><p>1, 2, 3, 4, 5, and 6 days post fertilization (dpf) correspond to 24, 48, 72, 96, 120, and 144 hr post fertilization (hpf), and 3 months post fertilization (mpf) corresponds to 90 dpf.</p></sec><sec id="s3-2"><title>CRISPR/Cas9 mutagenesis</title><p>CRISPR design platform (<ext-link ext-link-type="uri" xlink:href="http://crispr.mit.edu">http://crispr.mit.edu</ext-link>) was used to design sgRNAs against <italic>ins</italic> (targeting sequence: TCCAGTGTAAGCACTAACCCAGG) and <italic>insb</italic> (targeting sequence: GGATCGCAGTCTTCTCC) genes and constructs were assembled as described previously (<xref ref-type="bibr" rid="bib34">Jao et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Varshney et al., 2015</xref>). Briefly, a mixture of 25 pg gRNA with 300 pg <italic>Cas9</italic> mRNA was injected into one cell stage wild-type embryos. High-resolution melt analysis (HRMA) (Eco-Illumina) was used to determine efficiency of sgRNAs and genotype animals with <italic>ins</italic> primers 5’-GTGCTCTGTTGGTCCTGTTGG-3’ and 5’-CATCGACCAGATGAGATCCACAC-3’, and <italic>insb</italic> primers: 5’-AGTATTAATCCTGCTGCTGGCG-3’and 5’-GTGTAGAAGAAACCTCTAGGC-3’.</p></sec><sec id="s3-3"><title>Immunostaining and Nile Red staining</title><p>Immunostaining and imaging was performed as described previously (<xref ref-type="bibr" rid="bib82">Yang et al., 2018</xref>). Briefly, zebrafish larvae were euthanized and fixed overnight at 4°C with 4% paraformaldehyde (dissolved in buffer with composition: 22.6 mM NaH<sub>2</sub>PO<sub>4</sub>, 77 mM Na<sub>2</sub>HPO<sub>4</sub>, 120 μM CaCl<sub>2</sub>, 117 mM sucrose, pH 7.35). After two PBS washes, the larvae were deskinned, and permeabilized using PBS containing 0.5% TritonX-100% and 1% DMSO for 1 hr. Larvae were then incubated in blocking buffer (Dako) containing 5% goat serum for 2 hr, and incubated with primary antibody overnight at 4°C. Next, samples were washed 3 × 10 min with PBS containing 0.1% TritonX-100, incubated overnight at 4°C with secondary antibody and DAPI (10 µg/ml), washed 3 × 10 min and mounted in agarose. Antibody dilutions used are as follows: guinea pig anti-Insulin polyclonal (1:100, Thermo), mouse anti-Glucagon (1:300, Sigma), chicken anti-GFP (1:300, Aves), goat anti-guinea pig AlexaFluor568 (1:300, Thermo), goat anti-mouse AlexaFluor647 (1:300, Thermo), goat anti-chicken AlexaFluor488 (1:500, Thermo). Zeiss LSM700 (10X) and LSM800 (25X) were used to acquire data, and Imaris (Bitplane) was used to analyze data and to create maximum intensity projection images.</p><p>Neutral lipid staining using Nile Red dye was performed at a working concentration of 0.5 μg/mL for 30 min in the dark, followed by acquisition of fluorescent images using an LP490 filter on a Nikon SMZ25 stereomicroscope.</p></sec><sec id="s3-4"><title>Morpholino injections</title><p>For knockdown of gene expression, the following splice-blocking antisense morpholinos (Gene Tools, LLC) were injected into one-cell embryos at the indicated dosage per embryo: <italic>insa</italic> MO (4 ng, 5′-CCTCTACTTGACTTTCTTACCCAGA-3’) (<xref ref-type="bibr" rid="bib83">Ye et al., 2016</xref>) <italic>ar</italic> MO (1 ng, 5'-AGCAGAGCCGCCTCTTACCTGCCAT-3') (<xref ref-type="bibr" rid="bib58">Peal et al., 2011</xref>) standard control MO (4 or 1 ng, 5'-CCTCTTACCTCAGTTACAATTTATA-3').</p></sec><sec id="s3-5"><title>Intraperitoneal injections</title><p>Intraperitoneal injections and glucose level measurement in 6-month-old adult zebrafish was performed as described previously (<xref ref-type="bibr" rid="bib17">Curado et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Moss et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Eames et al., 2010</xref>). Briefly, ablation of β-cells in <italic>Tg</italic>(<italic>ins:Flag-NTR, cryaa:mCherry</italic>)<italic><sup>s950</sup></italic> (<xref ref-type="bibr" rid="bib4">Andersson et al., 2012</xref>) animals was performed by injecting 0.25 gm MTZ/kg body weight twice – on day 0 and day 1 – injecting twice improved the consistency of ablation. Flutamide (10 mg/kg) or vehicle (DMSO) was injected on days 2, 3 and 4. For injections, animals were anaesthetized using 0.02% Tricaine. On day 4, animals were euthanized and blood glucose was measured using a FreeStyle Freedom Lite Glucose Meter (Abbott).</p></sec><sec id="s3-6"><title>Larval glucose measurement</title><p>Free glucose level measurements were performed as described previously (<xref ref-type="bibr" rid="bib35">Jurczyk et al., 2011</xref>), with minor modifications. After desired treatment conditions, pools of 10 animals were collected in 1.5 mL Eppendorf tubes and frozen at −80°C after complete removal of water. For analysis, pools of wild-type embryos were resuspended in PBS. Samples were homogenized using a tissue homogenizer (Bullet Blender Gold, Next Advance). A Glucose Assay Kit (CBA086, Merck) was used for glucose detection. Different volumes were used for resuspension and glucose detection between wild types and <italic>ins</italic> mutants: wild-type samples were resuspended in a volume corresponding to 8 μl/animal and 8 μl was used for the glucose detection reaction. <italic>ins</italic> mutant embryos, due to their much higher glucose content, were resuspended in a volume corresponding to 16 μl/animal and only 2 μl was used for glucose detection.</p></sec><sec id="s3-7"><title>Transplantations</title><p>For the endoderm transplant experiment, <italic>sox32</italic> mRNA was transcribed using an Sp6 mMessage mMachine kit (Ambion). Using a micro-injector, 100 pg of <italic>sox32</italic> mRNA was injected into <italic>Tg(ins:DsRed)</italic> embryos, which served as donors. Embryos from an <italic>ins </italic>+/- incross served as hosts. Between the 1 k-cell and sphere stages (3–4 hpf), 15–20 cells from donor embryos were transplanted to host embryos, targeting the host mesendoderm at the margin of the blastoderm.</p></sec><sec id="s3-8"><title>Wholemount in situ hybridization</title><p>Larvae were collected at 120 hpf and fixed with 4% paraformaldehyde in PBS overnight at 4°C. In situ hybridization was performed as described previously (<xref ref-type="bibr" rid="bib73">Thisse and Thisse, 2008</xref>). <italic>ar</italic> digoxigenin-labelled anti-sense probe was synthesized using T7 polymerase (Roche) and DIG RNA labelling kit (Roche). The probe template was amplified using the following primers: <italic>ar</italic> ISH-forward 5′‐TGGAGTTTTTCCTTCCTCCA-3’ and <italic>ar</italic> ISH-reverse 5’- TAATACGACTCACTATAGGGTCATTTGTGGAACAGGATT- 3’, obtaining a 1100 bp probe as described previously (<xref ref-type="bibr" rid="bib28">Gorelick et al., 2008</xref>). Embryos were imaged on a Nikon SMZ25 stereomicroscope. Wild-type and mutant larvae were processed in the same tube and genotyped after the images were taken.</p></sec><sec id="s3-9"><title>Drug screening</title><p>3-mercaptopicolinic acid (3 MPA) treatment was performed at 1.5 mM concentration, metformin treatment at 250 μM concentration, and enzalutamide and bicalutamide treatments at 20 μM concentration. All other drug treatments were performed at 10 μM. For plate based screening, three 84 hpf <italic>ins</italic> mutant larvae were placed in each well of a 96-well plate in 200 μl of egg water buffered with 10 mM HEPES. All drug treatments were performed at 10 μM with 1% DMSO, unless otherwise stated. Drug treatment was performed from 84 to 120 hpf, after which each well was visually analyzed to assess toxicity. Subsequently, 100 μl of egg water was removed and 25 μl of 5X cell culture lysis buffer (Promega) was added. The plate was left shaking for 1 min at 750 rpm, and after gentle shaking at 150 rpm for 30 min, another round of vigorous shaking was performed for 1 min at 750 rpm. 8 μl from each well was used for the glucose detection reaction in a new 96-well plate using the Glucose Assay Kit (CBA086, Merck).</p><p>Drug libraries used in this screen are:</p><list list-type="order"><list-item><p>1440 molecules from Edelris Keymical Collection (Edelris) (0 hits).</p></list-item><list-item><p>285 molecules from the CLOUD collection (<xref ref-type="bibr" rid="bib43">Licciardello et al., 2017</xref>) (two hits).</p></list-item><list-item><p>156 molecules identified as <italic>insulin</italic> stimulators (<xref ref-type="bibr" rid="bib46">Matsuda et al., 2018</xref>) (one hit).</p></list-item><list-item><p>352 kinase inhibitors (SelleckChem) (0 hits)</p></list-item></list></sec><sec id="s3-10"><title>Transcriptomic analyses</title><p>For RNA-seq analysis, total RNA was isolated from 120 hpf zebrafish using the RNA Clean and Concentrator kit (Zymo Research), and samples were treated with DNase (RNase-free DNase Set, Promega) to avoid contamination by genomic DNA. Integrities of the isolated RNA and library preparation were verified with LabChip Gx Touch 24 (Perkin Elmer). 3 µg of total RNA was used as input for Truseq Stranded mRNA Library preparation following manufacturer’s ‘low sample’ protocol (Illumina). Sequencing was performed on NextSeq500 instrument (Illumina) using v2 chemistry, resulting in a minimum of 23M reads per library with 1 × 75 bp single end setup. The resulting raw reads were assessed for quality, adapter content and duplication rates with FastQC (<xref ref-type="bibr" rid="bib5">Andrews, 2010</xref>). Trimmomatic (version 0.33) was employed to trim reads after a quality drop below a mean of Q20 in a window of 5 nucleotides (<xref ref-type="bibr" rid="bib10">Bolger et al., 2014</xref>). Only reads between 30 and 150 nucleotides were cleared for further analyses. Trimmed and filtered reads were aligned with the Ensembl Zebrafish genome version DanRer10 (GRCz10.90), using STAR 2.4.0a with the parameter ‘--outFilterMismatchNoverLmax 0.1’ to increase the maximum ratio of mismatches to mapped length to 10% (<xref ref-type="bibr" rid="bib19">Dobin et al., 2013</xref>). The number of reads aligning to genes was counted with featureCounts 1.4.5-p1 tool from the Subread package (<xref ref-type="bibr" rid="bib42">Liao et al., 2014</xref>). Only the reads that mapped, at least partially, to within exons were admitted and aggregated for each gene. Reads that overlapped multiple genes or aligned to multiple regions were excluded. Differentially expressed genes were identified using DESeq2 version 1.62 (<xref ref-type="bibr" rid="bib44">Love et al., 2014</xref>). Maximum Benjamini-Hochberg corrected p-value of 0.05, along with a minimum combined mean of 5 reads, were set as inclusion criteria. The Ensembl annotation was enriched with UniProt data (release 06.06.2014) based on Ensembl gene identifiers (‘Activities at the Universal Protein Resource (UniProt),&quot; 2014). RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-7283. From this dataset, normalized read counts for <italic>ins</italic> and <italic>insb</italic> expression are:</p><p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Condition</th><th><italic>ins</italic></th><th><italic>insb</italic></th></tr></thead><tbody><tr><td>DMSO</td><td>183</td><td>1</td></tr><tr><td>Flutamide</td><td>176</td><td>2</td></tr><tr><td>Cyproterone</td><td>173</td><td>2</td></tr></tbody></table></table-wrap></p><p>Average normalized counts for <italic>ins</italic> and <italic>insb</italic> from transcriptomic data from zebrafish adult β-cells (<xref ref-type="bibr" rid="bib71">Tarifeño-Saldivia et al., 2017</xref>) are 4324351 and 0 respectively.</p><p>For microarray expression profiling, RNA was isolated from pooled 108 hpf zebrafish larvae using the RNA Clean and Concentrator kit (Zymo Research) combined with DNase digestion (RNase-free DNase Set, Promega). 10 animals were used for each pooled sample. Sample quality was tested using a Bioanalyzer and microarray analysis was performed by Oak Labs (Germany). Microarray data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-7282.</p></sec><sec id="s3-11"><title>Mass spectrometric analysis</title><p>For each of the three biological replicates within a genotype, protein was extracted from pools of 600 larvae at 5 dpf using 4% SDS in 0.1 M Tris/HCl, pH 7.6 and a tissue disrupting sterile pestle (Axygen) for lysis. After heating to 70°C at 800 rpm for 10 min and DNA shearing by sonication, cell debris was removed by centrifugation at 14.000 x g for 10 min and retaining the supernatant. Using a DC protein assay (BioRad), 7 mg of solubilized proteins per sample were acetone precipitated at −20°C overnight, followed by centrifugation at 14.000 x g for 10 min and washing the pellet using 90% acetone. After evaporation of residual acetone, samples were dissolved in urea buffer (6 M urea, 2 M thiourea, 10 mM HEPES, pH 8.0), followed by enzymatic peptidolysis as described (<xref ref-type="bibr" rid="bib29">Graumann et al., 2008</xref>; <xref ref-type="bibr" rid="bib39">Kim et al., 2018</xref>) with the following modifications: 10 mM dithiothreitol, 55 mM iodoacetamide and 100:1 protein to enzyme ratio of the proteolytic enzymes were used. Subsequent sample processing and data analyses were performed as described previously (<xref ref-type="bibr" rid="bib67">Sokol et al., 2018</xref>). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD012027. </p><p>Canonical pathway analysis was performed using Ingenuity Pathway Analysis (IPA) (Qiagen). Differentially expressed proteins from our study (log2FC ± 1.5) and from previously published datasets were subjected to a Comparison analysis in IPA. <italic>P-</italic>value maximum cut-off was set at 0.05 and the processes are listed according to those affected across most studies.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Drs. Rashmi Priya and Sonja Sievers for discussion and comments, Dr. Radhan Ramadass for expert help with microscopy, Jasmin Gäbges and Roshan Satapathy for experimental assistance, and Martin Laszczyk and the rest of the animal caretaking team for zebrafish care. These studies were supported by funding from the Max Planck Society (DYRS).</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Supervision, Validation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Software, Formal analysis, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Software, Formal analysis, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing—review and editing, Designed the CLOUD drug library</p></fn><fn fn-type="con" id="con9"><p>Resources, Software, Formal analysis, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish husbandry was performed under standard conditions in accordance with institutional (MPG) and national ethical and animal welfare guidelines approved by the ethics committee for animal experiments at the Regierungspräsidium Darmstadt, Germany (permit numbers B2/1017, B2/1041, B2/1089, B2/1138 and B2/Anz. 1007).</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.42209.011</object-id><label>Supplementary file 1.</label><caption><title>List of proteins with Log2FC &gt; 1 or Log2FC &lt; −1 from proteomic analyses comparing 120 hpf <italic>ins</italic> mutant and wild-type animals.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-42209-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.42209.012</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42209-transrepform-v2.pdf"/></supplementary-material><sec id="s6" sec-type="data-availability"><title>Data availability</title><p>Microarray and RNA-Seq data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-7282 and E-MTAB-7283 respectively. Proteomics data has been deposited in the PRIDE database (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/">https://www.ebi.ac.uk/pride/archive/</ext-link>) under accession number PXD012027.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Sri</surname><given-names>Teja Mullapudi</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Microarray analysis comparing zebrafish insulin mutants to non-mutants</data-title><source>ArrayExpress</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7282">E-MTAB-7282</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Sri</surname><given-names>Teja Mullapudi</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Effects of anti-androgenic compounds on zebrafish insulin mutants</data-title><source>ArrayExpress</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7283">E-MTAB-7283</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Anna</surname><given-names>M Sokol</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD012027">PXD012027</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amiri</surname> <given-names>M</given-names></name><name><surname>Golsorkhtabaramiri</surname> <given-names>M</given-names></name><name><surname>Esmaeilzadeh</surname> <given-names>S</given-names></name><name><surname>Ghofrani</surname> <given-names>F</given-names></name><name><surname>Bijani</surname> <given-names>A</given-names></name><name><surname>Ghorbani</surname> <given-names>L</given-names></name><name><surname>Delavar</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet</article-title><source>Journal of Reproduction &amp; Infertility</source><volume>15</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">25473629</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>Z</given-names></name><name><surname>Winnick</surname> <given-names>JJ</given-names></name><name><surname>Farmer</surname> <given-names>B</given-names></name><name><surname>Neal</surname> <given-names>D</given-names></name><name><surname>Lautz</surname> <given-names>M</given-names></name><name><surname>Irimia</surname> <given-names>JM</given-names></name><name><surname>Roach</surname> <given-names>PJ</given-names></name><name><surname>Cherrington</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo</article-title><source>Diabetes</source><volume>59</volume><fpage>2999</fpage><lpage>3007</lpage><pub-id pub-id-type="doi">10.2337/db10-0138</pub-id><pub-id pub-id-type="pmid">20823104</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Bosch</surname> <given-names>JA</given-names></name><name><surname>Goll</surname> <given-names>MG</given-names></name><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Dong</surname> <given-names>PD</given-names></name><name><surname>Shin</surname> <given-names>D</given-names></name><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Shin</surname> <given-names>CH</given-names></name><name><surname>Schlegel</surname> <given-names>A</given-names></name><name><surname>Halpern</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration</article-title><source>Developmental Biology</source><volume>334</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.07.017</pub-id><pub-id pub-id-type="pmid">19631206</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>O</given-names></name><name><surname>Adams</surname> <given-names>BA</given-names></name><name><surname>Yoo</surname> <given-names>D</given-names></name><name><surname>Ellis</surname> <given-names>GC</given-names></name><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>German</surname> <given-names>MS</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adenosine signaling promotes regeneration of pancreatic β cells in vivo</article-title><source>Cell Metabolism</source><volume>15</volume><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.04.018</pub-id><pub-id pub-id-type="pmid">22608007</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Andrews</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><source>FastQC: A Quality Control Tool for High Throughput Sequence Data</source></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronoff</surname> <given-names>SL</given-names></name><name><surname>Berkowitz</surname> <given-names>K</given-names></name><name><surname>Shreiner</surname> <given-names>B</given-names></name><name><surname>Want</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Glucose Metabolism and Regulation: Beyond Insulin and Glucagon</article-title><source>Diabetes Spectrum</source><volume>17</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.2337/diaspect.17.3.183</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>CJ</given-names></name><name><surname>Gross</surname> <given-names>JL</given-names></name><name><surname>Hennicken</surname> <given-names>D</given-names></name><name><surname>Iqbal</surname> <given-names>N</given-names></name><name><surname>Mansfield</surname> <given-names>TA</given-names></name><name><surname>List</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial</article-title><source>BMC Medicine</source><volume>11</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7015-11-43</pub-id><pub-id pub-id-type="pmid">23425012</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metformin: historical overview</article-title><source>Diabetologia</source><volume>60</volume><fpage>1566</fpage><lpage>1576</lpage><pub-id pub-id-type="doi">10.1007/s00125-017-4318-z</pub-id><pub-id pub-id-type="pmid">28776081</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boersema</surname> <given-names>PJ</given-names></name><name><surname>Raijmakers</surname> <given-names>R</given-names></name><name><surname>Lemeer</surname> <given-names>S</given-names></name><name><surname>Mohammed</surname> <given-names>S</given-names></name><name><surname>Heck</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics</article-title><source>Nature Protocols</source><volume>4</volume><fpage>484</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.21</pub-id><pub-id pub-id-type="pmid">19300442</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname> <given-names>AM</given-names></name><name><surname>Lohse</surname> <given-names>M</given-names></name><name><surname>Usadel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title><source>Bioinformatics</source><volume>30</volume><fpage>2114</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulton</surname> <given-names>CL</given-names></name><name><surname>Southam</surname> <given-names>E</given-names></name><name><surname>Garthwaite</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase</article-title><source>Neuroscience</source><volume>69</volume><fpage>699</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(95)00349-N</pub-id><pub-id pub-id-type="pmid">8596640</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braga</surname> <given-names>CP</given-names></name><name><surname>Boone</surname> <given-names>CH</given-names></name><name><surname>Grove</surname> <given-names>RA</given-names></name><name><surname>Adamcova</surname> <given-names>D</given-names></name><name><surname>Fernandes</surname> <given-names>AA</given-names></name><name><surname>Adamec</surname> <given-names>J</given-names></name><name><surname>de Magalhães Padilha</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Liver Proteome in Diabetes Type 1 Rat Model: Insulin-Dependent and -Independent Changes</article-title><source>OMICS: A Journal of Integrative Biology</source><volume>20</volume><fpage>711</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1089/omi.2016.0135</pub-id><pub-id pub-id-type="pmid">27849439</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuani</surname> <given-names>B</given-names></name><name><surname>Della-Morte</surname> <given-names>D</given-names></name><name><surname>Donadel</surname> <given-names>G</given-names></name><name><surname>Caratelli</surname> <given-names>S</given-names></name><name><surname>Bova</surname> <given-names>L</given-names></name><name><surname>Pastore</surname> <given-names>D</given-names></name><name><surname>De Canio</surname> <given-names>M</given-names></name><name><surname>D'Aguanno</surname> <given-names>S</given-names></name><name><surname>Coppola</surname> <given-names>A</given-names></name><name><surname>Pacifici</surname> <given-names>F</given-names></name><name><surname>Arriga</surname> <given-names>R</given-names></name><name><surname>Bellia</surname> <given-names>A</given-names></name><name><surname>Ferrelli</surname> <given-names>F</given-names></name><name><surname>Tesauro</surname> <given-names>M</given-names></name><name><surname>Federici</surname> <given-names>M</given-names></name><name><surname>Neri</surname> <given-names>A</given-names></name><name><surname>Bernardini</surname> <given-names>S</given-names></name><name><surname>Sbraccia</surname> <given-names>P</given-names></name><name><surname>Di Daniele</surname> <given-names>N</given-names></name><name><surname>Sconocchia</surname> <given-names>G</given-names></name><name><surname>Orlandi</surname> <given-names>A</given-names></name><name><surname>Urbani</surname> <given-names>A</given-names></name><name><surname>Lauro</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology</article-title><source>American Journal of Physiology-Endocrinology and Metabolism</source><volume>308</volume><fpage>E744</fpage><lpage>E755</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00447.2014</pub-id><pub-id pub-id-type="pmid">25714671</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carobbio</surname> <given-names>S</given-names></name><name><surname>Hagen</surname> <given-names>RM</given-names></name><name><surname>Lelliott</surname> <given-names>CJ</given-names></name><name><surname>Slawik</surname> <given-names>M</given-names></name><name><surname>Medina-Gomez</surname> <given-names>G</given-names></name><name><surname>Tan</surname> <given-names>CY</given-names></name><name><surname>Sicard</surname> <given-names>A</given-names></name><name><surname>Atherton</surname> <given-names>HJ</given-names></name><name><surname>Barbarroja</surname> <given-names>N</given-names></name><name><surname>Bjursell</surname> <given-names>M</given-names></name><name><surname>Bohlooly-Y</surname> <given-names>M</given-names></name><name><surname>Virtue</surname> <given-names>S</given-names></name><name><surname>Tuthill</surname> <given-names>A</given-names></name><name><surname>Lefai</surname> <given-names>E</given-names></name><name><surname>Laville</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Considine</surname> <given-names>RV</given-names></name><name><surname>Vidal</surname> <given-names>H</given-names></name><name><surname>Langin</surname> <given-names>D</given-names></name><name><surname>Oresic</surname> <given-names>M</given-names></name><name><surname>Tinahones</surname> <given-names>FJ</given-names></name><name><surname>Fernandez-Real</surname> <given-names>JM</given-names></name><name><surname>Griffin</surname> <given-names>JL</given-names></name><name><surname>Sethi</surname> <given-names>JK</given-names></name><name><surname>López</surname> <given-names>M</given-names></name><name><surname>Vidal-Puig</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity</article-title><source>Diabetes</source><volume>62</volume><fpage>3697</fpage><lpage>3708</lpage><pub-id pub-id-type="doi">10.2337/db12-1748</pub-id><pub-id pub-id-type="pmid">23919961</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhury</surname> <given-names>A</given-names></name><name><surname>Duvoor</surname> <given-names>C</given-names></name><name><surname>Reddy Dendi</surname> <given-names>VS</given-names></name><name><surname>Kraleti</surname> <given-names>S</given-names></name><name><surname>Chada</surname> <given-names>A</given-names></name><name><surname>Ravilla</surname> <given-names>R</given-names></name><name><surname>Marco</surname> <given-names>A</given-names></name><name><surname>Shekhawat</surname> <given-names>NS</given-names></name><name><surname>Montales</surname> <given-names>MT</given-names></name><name><surname>Kuriakose</surname> <given-names>K</given-names></name><name><surname>Sasapu</surname> <given-names>A</given-names></name><name><surname>Beebe</surname> <given-names>A</given-names></name><name><surname>Patil</surname> <given-names>N</given-names></name><name><surname>Musham</surname> <given-names>CK</given-names></name><name><surname>Lohani</surname> <given-names>GP</given-names></name><name><surname>Mirza</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management</article-title><source>Frontiers in Endocrinology</source><volume>8</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2017.00006</pub-id><pub-id pub-id-type="pmid">28167928</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curado</surname> <given-names>S</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nitroreductase-mediated cell/tissue ablation in zebrafish: a spatially and temporally controlled ablation method with applications in developmental and regeneration studies</article-title><source>Nature Protocols</source><volume>3</volume><fpage>948</fpage><lpage>954</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.58</pub-id><pub-id pub-id-type="pmid">18536643</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defronzo</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus</article-title><source>Diabetes</source><volume>58</volume><fpage>773</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.2337/db09-9028</pub-id><pub-id pub-id-type="pmid">19336687</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duvillié</surname> <given-names>B</given-names></name><name><surname>Cordonnier</surname> <given-names>N</given-names></name><name><surname>Deltour</surname> <given-names>L</given-names></name><name><surname>Dandoy-Dron</surname> <given-names>F</given-names></name><name><surname>Itier</surname> <given-names>JM</given-names></name><name><surname>Monthioux</surname> <given-names>E</given-names></name><name><surname>Jami</surname> <given-names>J</given-names></name><name><surname>Joshi</surname> <given-names>RL</given-names></name><name><surname>Bucchini</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Phenotypic alterations in insulin-deficient mutant mice</article-title><source>PNAS</source><volume>94</volume><fpage>5137</fpage><lpage>5140</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.10.5137</pub-id><pub-id pub-id-type="pmid">9144203</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eames</surname> <given-names>SC</given-names></name><name><surname>Philipson</surname> <given-names>LH</given-names></name><name><surname>Prince</surname> <given-names>VE</given-names></name><name><surname>Kinkel</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Blood sugar measurement in zebrafish reveals dynamics of glucose homeostasis</article-title><source>Zebrafish</source><volume>7</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1089/zeb.2009.0640</pub-id><pub-id pub-id-type="pmid">20515318</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenkranz</surname> <given-names>JR</given-names></name><name><surname>Lewis</surname> <given-names>NG</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name><name><surname>Roth</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Phlorizin: a review</article-title><source>Diabetes/Metabolism Research and Reviews</source><volume>21</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/dmrr.532</pub-id><pub-id pub-id-type="pmid">15624123</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmonem</surname> <given-names>M</given-names></name><name><surname>Berlingerio</surname> <given-names>S</given-names></name><name><surname>van den Heuvel</surname> <given-names>L</given-names></name><name><surname>de Witte</surname> <given-names>P</given-names></name><name><surname>Lowe</surname> <given-names>M</given-names></name><name><surname>Levtchenko</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic renal diseases: the emerging role of zebrafish models</article-title><source>Cells</source><volume>7</volume><elocation-id>130</elocation-id><pub-id pub-id-type="doi">10.3390/cells7090130</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnin</surname> <given-names>MS</given-names></name><name><surname>Donigian</surname> <given-names>JR</given-names></name><name><surname>Cohen</surname> <given-names>A</given-names></name><name><surname>Richon</surname> <given-names>VM</given-names></name><name><surname>Rifkind</surname> <given-names>RA</given-names></name><name><surname>Marks</surname> <given-names>PA</given-names></name><name><surname>Breslow</surname> <given-names>R</given-names></name><name><surname>Pavletich</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</article-title><source>Nature</source><volume>401</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/43710</pub-id><pub-id pub-id-type="pmid">10490031</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname> <given-names>T</given-names></name><name><surname>Sugiyama</surname> <given-names>Y</given-names></name><name><surname>Taketomi</surname> <given-names>S</given-names></name><name><surname>Sohda</surname> <given-names>T</given-names></name><name><surname>Kawamatsu</surname> <given-names>Y</given-names></name><name><surname>Iwatsuka</surname> <given-names>H</given-names></name><name><surname>Suzuoki</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent</article-title><source>Diabetes</source><volume>32</volume><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.2337/diab.32.9.804</pub-id><pub-id pub-id-type="pmid">6354788</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambineri</surname> <given-names>A</given-names></name><name><surname>Pelusi</surname> <given-names>C</given-names></name><name><surname>Genghini</surname> <given-names>S</given-names></name><name><surname>Morselli-Labate</surname> <given-names>AM</given-names></name><name><surname>Cacciari</surname> <given-names>M</given-names></name><name><surname>Pagotto</surname> <given-names>U</given-names></name><name><surname>Pasquali</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome</article-title><source>Clinical Endocrinology</source><volume>60</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2004.01973.x</pub-id><pub-id pub-id-type="pmid">14725687</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giebelstein</surname> <given-names>J</given-names></name><name><surname>Poschmann</surname> <given-names>G</given-names></name><name><surname>Højlund</surname> <given-names>K</given-names></name><name><surname>Schechinger</surname> <given-names>W</given-names></name><name><surname>Dietrich</surname> <given-names>JW</given-names></name><name><surname>Levin</surname> <given-names>K</given-names></name><name><surname>Beck-Nielsen</surname> <given-names>H</given-names></name><name><surname>Podwojski</surname> <given-names>K</given-names></name><name><surname>Stühler</surname> <given-names>K</given-names></name><name><surname>Meyer</surname> <given-names>HE</given-names></name><name><surname>Klein</surname> <given-names>HH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes</article-title><source>Diabetologia</source><volume>55</volume><fpage>1114</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2456-x</pub-id><pub-id pub-id-type="pmid">22282162</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelick</surname> <given-names>DA</given-names></name><name><surname>Watson</surname> <given-names>W</given-names></name><name><surname>Halpern</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Androgen receptor gene expression in the developing and adult zebrafish brain</article-title><source>Developmental Dynamics</source><volume>237</volume><fpage>2987</fpage><lpage>2995</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21700</pub-id><pub-id pub-id-type="pmid">18816841</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graumann</surname> <given-names>J</given-names></name><name><surname>Hubner</surname> <given-names>NC</given-names></name><name><surname>Kim</surname> <given-names>JB</given-names></name><name><surname>Ko</surname> <given-names>K</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Kumar</surname> <given-names>C</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Schöler</surname> <given-names>H</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>7</volume><fpage>672</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1074/mcp.M700460-MCP200</pub-id><pub-id pub-id-type="pmid">18045802</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Baeza-Raja</surname> <given-names>B</given-names></name><name><surname>Andersson</surname> <given-names>O</given-names></name><name><surname>Hasenkamp</surname> <given-names>L</given-names></name><name><surname>Hsiao</surname> <given-names>J</given-names></name><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Akassoglou</surname> <given-names>K</given-names></name><name><surname>Verdin</surname> <given-names>E</given-names></name><name><surname>Hirschey</surname> <given-names>MD</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism</article-title><source>Nature Chemical Biology</source><volume>9</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1136</pub-id><pub-id pub-id-type="pmid">23201900</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Reischauer</surname> <given-names>S</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Arnaout</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Little fish, big data: zebrafish as a model for cardiovascular and metabolic disease</article-title><source>Physiological Reviews</source><volume>97</volume><fpage>889</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1152/physrev.00038.2016</pub-id><pub-id pub-id-type="pmid">28468832</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Vogel</surname> <given-names>SS</given-names></name><name><surname>Liu</surname> <given-names>N</given-names></name><name><surname>Melton</surname> <given-names>DA</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of pancreatic development in living transgenic zebrafish embryos</article-title><source>Molecular and Cellular Endocrinology</source><volume>177</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/S0303-7207(01)00408-7</pub-id><pub-id pub-id-type="pmid">11377827</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>H</given-names></name><name><surname>Bowen</surname> <given-names>BP</given-names></name><name><surname>Lefort</surname> <given-names>N</given-names></name><name><surname>Flynn</surname> <given-names>CR</given-names></name><name><surname>De Filippis</surname> <given-names>EA</given-names></name><name><surname>Roberts</surname> <given-names>C</given-names></name><name><surname>Smoke</surname> <given-names>CC</given-names></name><name><surname>Meyer</surname> <given-names>C</given-names></name><name><surname>Højlund</surname> <given-names>K</given-names></name><name><surname>Yi</surname> <given-names>Z</given-names></name><name><surname>Mandarino</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes</article-title><source>Diabetes</source><volume>59</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.2337/db09-0214</pub-id><pub-id pub-id-type="pmid">19833877</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jao</surname> <given-names>LE</given-names></name><name><surname>Wente</surname> <given-names>SR</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system</article-title><source>PNAS</source><volume>110</volume><fpage>13904</fpage><lpage>13909</lpage><pub-id pub-id-type="doi">10.1073/pnas.1308335110</pub-id><pub-id pub-id-type="pmid">23918387</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurczyk</surname> <given-names>A</given-names></name><name><surname>Roy</surname> <given-names>N</given-names></name><name><surname>Bajwa</surname> <given-names>R</given-names></name><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Lipson</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>C</given-names></name><name><surname>Covassin</surname> <given-names>L</given-names></name><name><surname>Racki</surname> <given-names>WJ</given-names></name><name><surname>Rossini</surname> <given-names>AA</given-names></name><name><surname>Phillips</surname> <given-names>N</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Greiner</surname> <given-names>DL</given-names></name><name><surname>Brehm</surname> <given-names>MA</given-names></name><name><surname>Bortell</surname> <given-names>R</given-names></name><name><surname>diIorio</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish</article-title><source>General and Comparative Endocrinology</source><volume>170</volume><fpage>334</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.ygcen.2010.10.010</pub-id><pub-id pub-id-type="pmid">20965191</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname> <given-names>Y</given-names></name><name><surname>Agathon</surname> <given-names>A</given-names></name><name><surname>Alexander</surname> <given-names>J</given-names></name><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Waldron</surname> <given-names>S</given-names></name><name><surname>Yelon</surname> <given-names>D</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>casanova encodes a novel Sox-related protein necessary and sufficient for early endoderm formation in zebrafish</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>1493</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1101/gad.892301</pub-id><pub-id pub-id-type="pmid">11410530</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S-J</given-names></name><name><surname>Chae</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Mun</surname> <given-names>D-G</given-names></name><name><surname>Back</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>HY</given-names></name><name><surname>Park</surname> <given-names>KS</given-names></name><name><surname>Hwang</surname> <given-names>D</given-names></name><name><surname>Choi</surname> <given-names>SH</given-names></name><name><surname>Lee</surname> <given-names>S-W</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>A Protein Profile of Visceral Adipose Tissues Linked to Early Pathogenesis of Type 2 Diabetes Mellitus</article-title><source>Molecular; Cellular Proteomics</source><volume>13</volume><fpage>811</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1074/mcp.M113.035501</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>YD</given-names></name><name><surname>Kim</surname> <given-names>SG</given-names></name><name><surname>Hwang</surname> <given-names>SL</given-names></name><name><surname>Choi</surname> <given-names>HS</given-names></name><name><surname>Bae</surname> <given-names>JH</given-names></name><name><surname>Song</surname> <given-names>DK</given-names></name><name><surname>Im</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>B-cell translocation gene 2 regulates hepatic glucose homeostasis via induction of orphan nuclear receptor Nur77 in diabetic mouse model</article-title><source>Diabetes</source><volume>63</volume><fpage>1870</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.2337/db13-1368</pub-id><pub-id pub-id-type="pmid">24647738</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HT</given-names></name><name><surname>Yin</surname> <given-names>W</given-names></name><name><surname>Jin</surname> <given-names>YJ</given-names></name><name><surname>Panza</surname> <given-names>P</given-names></name><name><surname>Gunawan</surname> <given-names>F</given-names></name><name><surname>Grohmann</surname> <given-names>B</given-names></name><name><surname>Buettner</surname> <given-names>C</given-names></name><name><surname>Sokol</surname> <given-names>AM</given-names></name><name><surname>Preussner</surname> <given-names>J</given-names></name><name><surname>Guenther</surname> <given-names>S</given-names></name><name><surname>Kostin</surname> <given-names>S</given-names></name><name><surname>Ruppert</surname> <given-names>C</given-names></name><name><surname>Bhagwat</surname> <given-names>AM</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Graumann</surname> <given-names>J</given-names></name><name><surname>Looso</surname> <given-names>M</given-names></name><name><surname>Guenther</surname> <given-names>A</given-names></name><name><surname>Adelstein</surname> <given-names>RS</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4600</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06833-7</pub-id><pub-id pub-id-type="pmid">30389913</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Jung</surname> <given-names>DW</given-names></name><name><surname>Kim</surname> <given-names>WH</given-names></name><name><surname>Um</surname> <given-names>JI</given-names></name><name><surname>Yim</surname> <given-names>SH</given-names></name><name><surname>Oh</surname> <given-names>WK</given-names></name><name><surname>Williams</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Development of a highly visual, simple, and rapid test for the discovery of novel insulin mimetics in living vertebrates</article-title><source>ACS Chemical Biology</source><volume>8</volume><fpage>1803</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1021/cb4000162</pub-id><pub-id pub-id-type="pmid">23725454</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Page-McCaw</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FGF1 mediates overnutrition-induced compensatory beta-cell differentiation</article-title><source>Diabetes</source><volume>65</volume><fpage>96</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.2337/db15-0085</pub-id><pub-id pub-id-type="pmid">26420862</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licciardello</surname> <given-names>MP</given-names></name><name><surname>Ringler</surname> <given-names>A</given-names></name><name><surname>Markt</surname> <given-names>P</given-names></name><name><surname>Klepsch</surname> <given-names>F</given-names></name><name><surname>Lardeau</surname> <given-names>CH</given-names></name><name><surname>Sdelci</surname> <given-names>S</given-names></name><name><surname>Schirghuber</surname> <given-names>E</given-names></name><name><surname>Müller</surname> <given-names>AC</given-names></name><name><surname>Caldera</surname> <given-names>M</given-names></name><name><surname>Wagner</surname> <given-names>A</given-names></name><name><surname>Herzog</surname> <given-names>R</given-names></name><name><surname>Penz</surname> <given-names>T</given-names></name><name><surname>Schuster</surname> <given-names>M</given-names></name><name><surname>Boidol</surname> <given-names>B</given-names></name><name><surname>Dürnberger</surname> <given-names>G</given-names></name><name><surname>Folkvaljon</surname> <given-names>Y</given-names></name><name><surname>Stattin</surname> <given-names>P</given-names></name><name><surname>Ivanov</surname> <given-names>V</given-names></name><name><surname>Colinge</surname> <given-names>J</given-names></name><name><surname>Bock</surname> <given-names>C</given-names></name><name><surname>Kratochwill</surname> <given-names>K</given-names></name><name><surname>Menche</surname> <given-names>J</given-names></name><name><surname>Bennett</surname> <given-names>KL</given-names></name><name><surname>Kubicek</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor</article-title><source>Nature Chemical Biology</source><volume>13</volume><fpage>771</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2382</pub-id><pub-id pub-id-type="pmid">28530711</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname> <given-names>BS</given-names></name><name><surname>Johnson</surname> <given-names>JR</given-names></name><name><surname>Cohen</surname> <given-names>MH</given-names></name><name><surname>Justice</surname> <given-names>R</given-names></name><name><surname>Pazdur</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma</article-title><source>The Oncologist</source><volume>12</volume><fpage>1247</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.12-10-1247</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Mullapudi</surname> <given-names>ST</given-names></name><name><surname>Yang</surname> <given-names>YHC</given-names></name><name><surname>Masaki</surname> <given-names>H</given-names></name><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Whole-Organism Chemical Screening Identifies Modulators of Pancreatic β-Cell Function</article-title><source>Diabetes</source><volume>67</volume><fpage>2268</fpage><lpage>2279</lpage><pub-id pub-id-type="doi">10.2337/db17-1223</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehran</surname> <given-names>AE</given-names></name><name><surname>Templeman</surname> <given-names>NM</given-names></name><name><surname>Brigidi</surname> <given-names>GS</given-names></name><name><surname>Lim</surname> <given-names>GE</given-names></name><name><surname>Chu</surname> <given-names>KY</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Botezelli</surname> <given-names>JD</given-names></name><name><surname>Asadi</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>BG</given-names></name><name><surname>Kieffer</surname> <given-names>TJ</given-names></name><name><surname>Bamji</surname> <given-names>SX</given-names></name><name><surname>Clee</surname> <given-names>SM</given-names></name><name><surname>Johnson</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hyperinsulinemia drives diet-induced obesity independently of brain insulin production</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>723</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.10.019</pub-id><pub-id pub-id-type="pmid">23217255</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchin</surname> <given-names>JEN</given-names></name><name><surname>Rawls</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A classification system for zebrafish adipose tissues</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>797</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1242/dmm.025759</pub-id><pub-id pub-id-type="pmid">28348140</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname> <given-names>JB</given-names></name><name><surname>Koustubhan</surname> <given-names>P</given-names></name><name><surname>Greenman</surname> <given-names>M</given-names></name><name><surname>Parsons</surname> <given-names>MJ</given-names></name><name><surname>Walter</surname> <given-names>I</given-names></name><name><surname>Moss</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Regeneration of the pancreas in adult zebrafish</article-title><source>Diabetes</source><volume>58</volume><fpage>1844</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.2337/db08-0628</pub-id><pub-id pub-id-type="pmid">19491207</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname> <given-names>E</given-names></name><name><surname>Ohlendieck</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Proteomic profiling of non-obese type 2 diabetic skeletal muscle</article-title><source>International Journal of Molecular Medicine</source><volume>25</volume><fpage>445</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">20127051</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakae</surname> <given-names>J</given-names></name><name><surname>Kido</surname> <given-names>Y</given-names></name><name><surname>Accili</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Distinct and overlapping functions of insulin and IGF-I receptors</article-title><source>Endocrine Reviews</source><volume>22</volume><fpage>818</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1210/edrv.22.6.0452</pub-id><pub-id pub-id-type="pmid">11739335</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname> <given-names>AK</given-names></name><name><surname>Ryu</surname> <given-names>JH</given-names></name><name><surname>Jin</surname> <given-names>YN</given-names></name><name><surname>Roberts</surname> <given-names>LD</given-names></name><name><surname>Dejam</surname> <given-names>A</given-names></name><name><surname>Gerszten</surname> <given-names>RE</given-names></name><name><surname>Peterson</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PTPMT1 Inhibition Lowers Glucose through Succinate Dehydrogenase Phosphorylation</article-title><source>Cell Reports</source><fpage>694</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.010</pub-id><pub-id pub-id-type="pmid">25660020</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname> <given-names>G</given-names></name><name><surname>Allard</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Mauvais-Jarvis</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The role of androgens in metabolism, obesity, and diabetes in males and females</article-title><source>Obesity</source><volume>23</volume><fpage>713</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1002/oby.21033</pub-id><pub-id pub-id-type="pmid">25755205</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname> <given-names>G</given-names></name><name><surname>Allard</surname> <given-names>C</given-names></name><name><surname>Morford</surname> <given-names>JJ</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Molinas</surname> <given-names>AJR</given-names></name><name><surname>Butcher</surname> <given-names>SM</given-names></name><name><surname>Fine</surname> <given-names>NHF</given-names></name><name><surname>Blandino-Rosano</surname> <given-names>M</given-names></name><name><surname>Sure</surname> <given-names>VN</given-names></name><name><surname>Yu</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>R</given-names></name><name><surname>Münzberg</surname> <given-names>H</given-names></name><name><surname>Jacobson</surname> <given-names>DA</given-names></name><name><surname>Katakam</surname> <given-names>PV</given-names></name><name><surname>Hodson</surname> <given-names>DJ</given-names></name><name><surname>Bernal-Mizrachi</surname> <given-names>E</given-names></name><name><surname>Zsombok</surname> <given-names>A</given-names></name><name><surname>Mauvais-Jarvis</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>98670</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.98607</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>UH</given-names></name><name><surname>Denroche</surname> <given-names>HC</given-names></name><name><surname>Mojibian</surname> <given-names>M</given-names></name><name><surname>Covey</surname> <given-names>SD</given-names></name><name><surname>Kieffer</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insulin Knockout Mice Have Extended Survival but Volatile Blood Glucose Levels on Leptin Therapy</article-title><source>Endocrinology</source><volume>157</volume><fpage>1007</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1210/en.2015-1890</pub-id><pub-id pub-id-type="pmid">26696124</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochman</surname> <given-names>AR</given-names></name><name><surname>Lipinski</surname> <given-names>CA</given-names></name><name><surname>Handler</surname> <given-names>JA</given-names></name><name><surname>Reaume</surname> <given-names>AG</given-names></name><name><surname>Saporito</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>342</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1124/jpet.112.192187</pub-id><pub-id pub-id-type="pmid">22431203</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papasani</surname> <given-names>MR</given-names></name><name><surname>Robison</surname> <given-names>BD</given-names></name><name><surname>Hardy</surname> <given-names>RW</given-names></name><name><surname>Hill</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Early developmental expression of two insulins in zebrafish (Danio rerio)</article-title><source>Physiological Genomics</source><volume>27</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.00012.2006</pub-id><pub-id pub-id-type="pmid">16849636</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peal</surname> <given-names>DS</given-names></name><name><surname>Mills</surname> <given-names>RW</given-names></name><name><surname>Lynch</surname> <given-names>SN</given-names></name><name><surname>Mosley</surname> <given-names>JM</given-names></name><name><surname>Lim</surname> <given-names>E</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>January</surname> <given-names>CT</given-names></name><name><surname>Peterson</surname> <given-names>RT</given-names></name><name><surname>Milan</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen</article-title><source>Circulation</source><volume>123</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.003731</pub-id><pub-id pub-id-type="pmid">21098441</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raynaud</surname> <given-names>JP</given-names></name><name><surname>Bonne</surname> <given-names>C</given-names></name><name><surname>Bouton</surname> <given-names>MM</given-names></name><name><surname>Lagace</surname> <given-names>L</given-names></name><name><surname>Labrie</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues</article-title><source>Journal of Steroid Biochemistry</source><volume>11</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/0022-4731(79)90281-4</pub-id><pub-id pub-id-type="pmid">385986</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rena</surname> <given-names>G</given-names></name><name><surname>Hardie</surname> <given-names>DG</given-names></name><name><surname>Pearson</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The mechanisms of action of metformin</article-title><source>Diabetologia</source><volume>60</volume><fpage>1577</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1007/s00125-017-4342-z</pub-id><pub-id pub-id-type="pmid">28776086</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richon</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor</article-title><source>British Journal of Cancer</source><volume>95</volume><fpage>S2</fpage><lpage>S6</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6603463</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname> <given-names>I</given-names></name><name><surname>Serter</surname> <given-names>R</given-names></name><name><surname>Karakurt</surname> <given-names>F</given-names></name><name><surname>Demirbas</surname> <given-names>B</given-names></name><name><surname>Culha</surname> <given-names>C</given-names></name><name><surname>Taskapan</surname> <given-names>C</given-names></name><name><surname>Kosar</surname> <given-names>F</given-names></name><name><surname>Aral</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study</article-title><source>Gynecological Endocrinology</source><volume>19</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1080/09513590400004736</pub-id><pub-id pub-id-type="pmid">15697072</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname> <given-names>T</given-names></name><name><surname>Kikuchi</surname> <given-names>Y</given-names></name><name><surname>Kuroiwa</surname> <given-names>A</given-names></name><name><surname>Takeda</surname> <given-names>H</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The yolk syncytial layer regulates myocardial migration by influencing extracellular matrix assembly in zebrafish</article-title><source>Development</source><volume>133</volume><fpage>4063</fpage><lpage>4072</lpage><pub-id pub-id-type="doi">10.1242/dev.02581</pub-id><pub-id pub-id-type="pmid">17008449</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saporito</surname> <given-names>MS</given-names></name><name><surname>Ochman</surname> <given-names>AR</given-names></name><name><surname>Lipinski</surname> <given-names>CA</given-names></name><name><surname>Handler</surname> <given-names>JA</given-names></name><name><surname>Reaume</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>342</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1124/jpet.112.192096</pub-id><pub-id pub-id-type="pmid">22473614</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanik</surname> <given-names>MH</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Škrha</surname> <given-names>J</given-names></name><name><surname>Dankner</surname> <given-names>R</given-names></name><name><surname>Zick</surname> <given-names>Y</given-names></name><name><surname>Roth</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Insulin Resistance and Hyperinsulinemia</article-title><source>Diabetes Care</source><volume>31</volume><elocation-id>S262</elocation-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soccio</surname> <given-names>RE</given-names></name><name><surname>Chen</surname> <given-names>ER</given-names></name><name><surname>Lazar</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes</article-title><source>Cell Metabolism</source><volume>20</volume><fpage>573</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.08.005</pub-id><pub-id pub-id-type="pmid">25242225</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokol</surname> <given-names>AM</given-names></name><name><surname>Uszczynska-Ratajczak</surname> <given-names>B</given-names></name><name><surname>Collins</surname> <given-names>MM</given-names></name><name><surname>Bazala</surname> <given-names>M</given-names></name><name><surname>Topf</surname> <given-names>U</given-names></name><name><surname>Lundegaard</surname> <given-names>PR</given-names></name><name><surname>Sugunan</surname> <given-names>S</given-names></name><name><surname>Guenther</surname> <given-names>S</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Graumann</surname> <given-names>J</given-names></name><name><surname>Chan</surname> <given-names>SSL</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Chacinska</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of the Mia40a oxidoreductase leads to hepato-pancreatic insufficiency in zebrafish</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007743</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007743</pub-id><pub-id pub-id-type="pmid">30457989</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafford</surname> <given-names>D</given-names></name><name><surname>White</surname> <given-names>RJ</given-names></name><name><surname>Kinkel</surname> <given-names>MD</given-names></name><name><surname>Linville</surname> <given-names>A</given-names></name><name><surname>Schilling</surname> <given-names>TF</given-names></name><name><surname>Prince</surname> <given-names>VE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Retinoids signal directly to zebrafish endoderm to specify insulin-expressing beta-cells</article-title><source>Development</source><volume>133</volume><fpage>949</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1242/dev.02263</pub-id><pub-id pub-id-type="pmid">16452093</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanford</surname> <given-names>KI</given-names></name><name><surname>Goodyear</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle</article-title><source>Advances in Physiology Education</source><volume>38</volume><fpage>308</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1152/advan.00080.2014</pub-id><pub-id pub-id-type="pmid">25434013</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname> <given-names>CM</given-names></name><name><surname>Emanuelli</surname> <given-names>B</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Critical nodes in signalling pathways: insights into insulin action</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>7</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/nrm1837</pub-id><pub-id pub-id-type="pmid">16493415</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarifeño-Saldivia</surname> <given-names>E</given-names></name><name><surname>Lavergne</surname> <given-names>A</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Padamata</surname> <given-names>K</given-names></name><name><surname>Bergemann</surname> <given-names>D</given-names></name><name><surname>Voz</surname> <given-names>ML</given-names></name><name><surname>Manfroid</surname> <given-names>I</given-names></name><name><surname>Peers</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptome analysis of pancreatic cells across distant species highlights novel important regulator genes</article-title><source>BMC Biology</source><volume>15</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-017-0362-x</pub-id><pub-id pub-id-type="pmid">28327131</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teutsch</surname> <given-names>G</given-names></name><name><surname>Goubet</surname> <given-names>F</given-names></name><name><surname>Battmann</surname> <given-names>T</given-names></name><name><surname>Bonfils</surname> <given-names>A</given-names></name><name><surname>Bouchoux</surname> <given-names>F</given-names></name><name><surname>Cerede</surname> <given-names>E</given-names></name><name><surname>Gofflo</surname> <given-names>D</given-names></name><name><surname>Gaillard-Kelly</surname> <given-names>M</given-names></name><name><surname>Philibert</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor</article-title><source>The Journal of Steroid Biochemistry and Molecular Biology</source><volume>48</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/0960-0760(94)90257-7</pub-id><pub-id pub-id-type="pmid">8136296</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>C</given-names></name><name><surname>Ouk</surname> <given-names>S</given-names></name><name><surname>Clegg</surname> <given-names>NJ</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Watson</surname> <given-names>PA</given-names></name><name><surname>Arora</surname> <given-names>V</given-names></name><name><surname>Wongvipat</surname> <given-names>J</given-names></name><name><surname>Smith-Jones</surname> <given-names>PM</given-names></name><name><surname>Yoo</surname> <given-names>D</given-names></name><name><surname>Kwon</surname> <given-names>A</given-names></name><name><surname>Wasielewska</surname> <given-names>T</given-names></name><name><surname>Welsbie</surname> <given-names>D</given-names></name><name><surname>Chen</surname> <given-names>CD</given-names></name><name><surname>Higano</surname> <given-names>CS</given-names></name><name><surname>Beer</surname> <given-names>TM</given-names></name><name><surname>Hung</surname> <given-names>DT</given-names></name><name><surname>Scher</surname> <given-names>HI</given-names></name><name><surname>Jung</surname> <given-names>ME</given-names></name><name><surname>Sawyers</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Development of a second-generation antiandrogen for treatment of advanced prostate cancer</article-title><source>Science</source><volume>324</volume><fpage>787</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1126/science.1168175</pub-id><pub-id pub-id-type="pmid">19359544</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname> <given-names>N</given-names></name><name><surname>Ninov</surname> <given-names>N</given-names></name><name><surname>Delawary</surname> <given-names>M</given-names></name><name><surname>Osman</surname> <given-names>S</given-names></name><name><surname>Roh</surname> <given-names>AS</given-names></name><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Whole organism high content screening identifies stimulators of pancreatic beta-cell proliferation</article-title><source>PLoS ONE</source><volume>9</volume><elocation-id>e104112</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0104112</pub-id><pub-id pub-id-type="pmid">25117518</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>UniProt Consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Activities at the Universal Protein Resource (UniProt)</article-title><source>Nucleic Acids Research</source><volume>198</volume><elocation-id>D191</elocation-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valle</surname> <given-names>A</given-names></name><name><surname>Catalán</surname> <given-names>V</given-names></name><name><surname>Rodríguez</surname> <given-names>A</given-names></name><name><surname>Rotellar</surname> <given-names>F</given-names></name><name><surname>Valentí</surname> <given-names>V</given-names></name><name><surname>Silva</surname> <given-names>C</given-names></name><name><surname>Salvador</surname> <given-names>J</given-names></name><name><surname>Frühbeck</surname> <given-names>G</given-names></name><name><surname>Gómez-Ambrosi</surname> <given-names>J</given-names></name><name><surname>Roca</surname> <given-names>P</given-names></name><name><surname>Oliver</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects</article-title><source>Liver International</source><volume>32</volume><fpage>951</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2012.02765.x</pub-id><pub-id pub-id-type="pmid">22340678</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname> <given-names>GK</given-names></name><name><surname>Pei</surname> <given-names>W</given-names></name><name><surname>LaFave</surname> <given-names>MC</given-names></name><name><surname>Idol</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Gallardo</surname> <given-names>V</given-names></name><name><surname>Carrington</surname> <given-names>B</given-names></name><name><surname>Bishop</surname> <given-names>K</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Harper</surname> <given-names>U</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>Prakash</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Sood</surname> <given-names>R</given-names></name><name><surname>Ledin</surname> <given-names>J</given-names></name><name><surname>Burgess</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9</article-title><source>Genome Research</source><volume>25</volume><fpage>1030</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1101/gr.186379.114</pub-id><pub-id pub-id-type="pmid">26048245</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>York</surname> <given-names>NW</given-names></name><name><surname>Nichols</surname> <given-names>CG</given-names></name><name><surname>Remedi</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy</article-title><source>Cell Metabolism</source><volume>19</volume><fpage>872</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.03.010</pub-id><pub-id pub-id-type="pmid">24746806</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>DT</given-names></name><name><surname>Eroglu</surname> <given-names>AU</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Sengupta</surname> <given-names>S</given-names></name><name><surname>Ding</surname> <given-names>D</given-names></name><name><surname>Rajpurohit</surname> <given-names>SK</given-names></name><name><surname>Walker</surname> <given-names>SL</given-names></name><name><surname>Ji</surname> <given-names>H</given-names></name><name><surname>Qian</surname> <given-names>J</given-names></name><name><surname>Mumm</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates</article-title><source>Nature Protocols</source><volume>11</volume><fpage>2432</fpage><lpage>2453</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.142</pub-id><pub-id pub-id-type="pmid">27831568</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>RJ</given-names></name><name><surname>Collins</surname> <given-names>JE</given-names></name><name><surname>Sealy</surname> <given-names>IM</given-names></name><name><surname>Wali</surname> <given-names>N</given-names></name><name><surname>Dooley</surname> <given-names>CM</given-names></name><name><surname>Digby</surname> <given-names>Z</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name><name><surname>Murphy</surname> <given-names>DN</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Füllgrabe</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>MP</given-names></name><name><surname>Enright</surname> <given-names>AJ</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A high-resolution mRNA expression time course of embryonic development in zebrafish</article-title><source>eLife</source><volume>6</volume><elocation-id>e30860</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30860</pub-id><pub-id pub-id-type="pmid">29144233</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>YHC</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A new mode of pancreatic islet innervation revealed by live imaging in zebrafish</article-title><source>eLife</source><volume>7</volume><elocation-id>e34519</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34519</pub-id><pub-id pub-id-type="pmid">29916364</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>L</given-names></name><name><surname>Robertson</surname> <given-names>MA</given-names></name><name><surname>Mastracci</surname> <given-names>TL</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration</article-title><source>Developmental Biology</source><volume>409</volume><fpage>354</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.12.003</pub-id><pub-id pub-id-type="pmid">26658317</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabielski</surname> <given-names>P</given-names></name><name><surname>Lanza</surname> <given-names>IR</given-names></name><name><surname>Gopala</surname> <given-names>S</given-names></name><name><surname>Heppelmann</surname> <given-names>CJ</given-names></name><name><surname>Bergen</surname> <given-names>HR</given-names></name><name><surname>Dasari</surname> <given-names>S</given-names></name><name><surname>Nair</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice</article-title><source>Diabetes</source><volume>65</volume><fpage>561</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.2337/db15-0823</pub-id><pub-id pub-id-type="pmid">26718503</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42209.020</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>White</surname><given-names>Richard M</given-names></name><role>Reviewing Editor</role><aff><institution>Memorial Sloan Kettering Cancer Center</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Mark McCarthy as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Charles Hong (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Overall, the reviewers were enthusiastic about this manuscript and think that it adds an important new tool to the glucose homeostasis field. It will be of great interest to both zebrafish and non-zebrafish researchers and imagine it can be easily extended to identify even more pathways. The requests from the reviewers are relatively minor.</p><p>– More commentary on the efficacy of known anti-diabetic drugs, as depicted in Figure 3A, would be helpful in arriving at an understanding of the model itself. Why do some drugs work and others not, and what does this tell us about the strengths/limitations of the model?</p><p>– Similarly, more commentary on the human effects of the three hits would be helpful. In particular, hyperglycemia is a well-known side effect of vorinostat, so discussion of why zebrafish mutants respond differently would be helpful.</p><p>– It would be interesting to know if the glucose lowering effects of known drugs or novel hits prolonged survival in the <italic>ins</italic> mutants.</p><p>– Because the <italic>insb</italic> gene is apparently still intact in the <italic>ins</italic> mutants (although presumably expressed only at a low level), it might be helpful to show that the effects reported as insulin independent are also independent of <italic>insb</italic>.</p><p>– In Figure 3C, it appears that there are many more than 3 compounds that lowered glucose levels in the 2 replicate experiments. I assume of these, only 3 were found to &quot;reproducibly reduced glucose levels upon retesting…&quot; Can the authors explicitly state the number of compounds that made their prespecified cut-off in 2 replicates (perhaps in the figure legend)? This assay will be of interest to many investigators, and it would be good to know what the hit confirmation rate is.</p><p>– In Figure 4F, it appears that there is a trend toward lower fasting glucose levels in &quot;diabetic&quot; adult fish treated with flutamide, but this does not reach statistical significance (p=0.069). Looking at the data, this is likely due to the fact that only 5 fish were in the DMSO group. A few additional diabetic adult fish treated with DMSO would enable authors to make a more definitive conclusion.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42209.021</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Overall, the reviewers were enthusiastic about this manuscript and think that it adds an important new tool to the glucose homeostasis field. It will be of great interest to both zebrafish and non-zebrafish researchers and imagine it can be easily extended to identify even more pathways. The requests from the reviewers are relatively minor.</p><p>– More commentary on the efficacy of known anti-diabetic drugs, as depicted in Figure 3A, would be helpful in arriving at an understanding of the model itself. Why do some drugs work and others not, and what does this tell us about the strengths/limitations of the model?</p></disp-quote><p>We have incorporated additional points into the Results and Discussion section to discuss the implications of our results with the known anti-diabetic drugs. To provide greater detail, we have also included a Pck1 inhibitor, 3-MPA, in our analyses in Figure 3A.</p><disp-quote content-type="editor-comment"><p>– Similarly, more commentary on the human effects of the three hits would be helpful. In particular, hyperglycemia is a well-known side effect of vorinostat, so discussion of why zebrafish mutants respond differently would be helpful.</p></disp-quote><p>We have incorporated additional points into the Results and Discussion section to address this question.</p><disp-quote content-type="editor-comment"><p>– It would be interesting to know if the glucose lowering effects of known drugs or novel hits prolonged survival in the ins mutants.</p></disp-quote><p>Glucose lowering drugs did not prolong survival of the <italic>ins</italic> mutants.</p><p>Insulin plays a versatile role in growth and metabolic signaling during development (Taniguchi et al., 2006). While our study contributes to the search for a small molecule as potent as insulin, we do not expect that lowering glucose levels alone will normalize all the processes dysregulated in <italic>ins</italic> mutants. We have now incorporated this information into the Results and Discussion section.</p><disp-quote content-type="editor-comment"><p>– Because the insb gene is apparently still intact in the ins mutants (although presumably expressed only at a low level), it might be helpful to show that the effects reported as insulin independent are also independent of insb.</p></disp-quote><p><italic>insb</italic> expression peaks at 6 hours post fertilization (hpf) and is drastically decreased by 120 hpf (Papasani et al., 2006) (Figure 1—figure supplement 1F), and it is undetectable in adult β-cells (Tarifeño-Saldivia et al., 2017) with 0 normalized counts, as opposed to over 4 million for <italic>ins</italic>.</p><p>Our RNA-Seq analyses on 120 hpf <italic>ins</italic> mutants show normalized read count for <italic>insb</italic> transcript to be 1, which is minimal compared to 181 for <italic>ins</italic>. Additionally, upon treatment with the AR antagonists, Flutamide and Cyproterone, the normalized read counts for <italic>insb</italic> remain at a low level of 2 units (ArrayExpress accession number: E-MTAB-7283<underline>)</underline>. Together, these data suggest that it is unlikely that <italic>insb</italic> could be contributing to the metabolic effects we observe. We have now incorporated these data into the Materials and methods section, under ‘Transcriptomic analyses’.</p><disp-quote content-type="editor-comment"><p>– In Figure 3C, it appears that there are many more than 3 compounds that lowered glucose levels in the 2 replicate experiments. I assume of these, only 3 were found to &quot;reproducibly reduced glucose levels upon retesting…&quot; Can the authors explicitly state the number of compounds that made their prespecified cut-off in 2 replicates (perhaps in the figure legend)? This assay will be of interest to many investigators, and it would be good to know what the hit confirmation rate is.</p></disp-quote><p>This information has been added to the legend of Figure 3.</p><disp-quote content-type="editor-comment"><p>– In Figure 4F, it appears that there is a trend toward lower fasting glucose levels in &quot;diabetic&quot; adult fish treated with flutamide, but this does not reach statistical significance (p=0.069). Looking at the data, this is likely due to the fact that only 5 fish were in the DMSO group. A few additional diabetic adult fish treated with DMSO would enable authors to make a more definitive conclusion.</p></disp-quote><p>We have now performed the experiment with additional animals and modified Figure 4 accordingly.</p></body></sub-article></article>